1. Home
  2. SNGX vs DDC Comparison

SNGX vs DDC Comparison

Compare SNGX & DDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • DDC
  • Stock Information
  • Founded
  • SNGX 1987
  • DDC 2012
  • Country
  • SNGX United States
  • DDC United States
  • Employees
  • SNGX N/A
  • DDC N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • DDC Metal Mining
  • Sector
  • SNGX Health Care
  • DDC Basic Materials
  • Exchange
  • SNGX Nasdaq
  • DDC Nasdaq
  • Market Cap
  • SNGX 7.4M
  • DDC 12.7M
  • IPO Year
  • SNGX 1987
  • DDC 2023
  • Fundamental
  • Price
  • SNGX $2.44
  • DDC $0.19
  • Analyst Decision
  • SNGX
  • DDC Strong Buy
  • Analyst Count
  • SNGX 0
  • DDC 1
  • Target Price
  • SNGX N/A
  • DDC $3.00
  • AVG Volume (30 Days)
  • SNGX 40.8K
  • DDC 233.2K
  • Earning Date
  • SNGX 03-14-2025
  • DDC 01-01-0001
  • Dividend Yield
  • SNGX N/A
  • DDC N/A
  • EPS Growth
  • SNGX N/A
  • DDC N/A
  • EPS
  • SNGX N/A
  • DDC N/A
  • Revenue
  • SNGX $364,183.00
  • DDC $32,882,772.00
  • Revenue This Year
  • SNGX N/A
  • DDC N/A
  • Revenue Next Year
  • SNGX $76.64
  • DDC N/A
  • P/E Ratio
  • SNGX N/A
  • DDC N/A
  • Revenue Growth
  • SNGX N/A
  • DDC 18.16
  • 52 Week Low
  • SNGX $1.83
  • DDC $0.12
  • 52 Week High
  • SNGX $14.88
  • DDC $2.53
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 46.48
  • DDC 59.98
  • Support Level
  • SNGX $2.25
  • DDC $0.15
  • Resistance Level
  • SNGX $2.60
  • DDC $0.17
  • Average True Range (ATR)
  • SNGX 0.15
  • DDC 0.02
  • MACD
  • SNGX 0.04
  • DDC 0.00
  • Stochastic Oscillator
  • SNGX 63.64
  • DDC 85.90

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About DDC DDC Enterprise Limited

DDC Enterprise Ltd is a content driven consumer brand offering easy, convenient ready-to-heat , ready-to-cook and plant-based meal products i.e. meal products consisting largely or solely of vegetables, fruits, grains and other foods derived from plant-based protein, rather than animal protein) while promoting healthier lifestyle choices to Millennial and Generation Z customer-base. It is also engaged in the provision of advertising services and the operation of experience stores to offer cooking classes.

Share on Social Networks: